141 related articles for article (PubMed ID: 29764180)
1. Symptom control, treatment-induced nausea prophylaxis, and palliative radiation therapy.
Simone CB
Ann Palliat Med; 2018 Apr; 7(2):E2-E4. PubMed ID: 29764180
[No Abstract] [Full Text] [Related]
2. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients.
Fonte C; Fatigoni S; Roila F
Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971
[TBL] [Abstract][Full Text] [Related]
3. Antiemetic strategies for high-dose chemoradiotherapy-induced nausea and vomiting.
Spitzer TR; Grunberg SM; Dicato MA
Support Care Cancer; 1998 May; 6(3):233-6. PubMed ID: 9629875
[TBL] [Abstract][Full Text] [Related]
4. Olanzapine in the treatment of refractory nausea and vomiting: a case report and review of the literature.
Langley-DeGroot M; Ma JD; Hirst J; Roeland EJ
J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):148-52. PubMed ID: 26095486
[TBL] [Abstract][Full Text] [Related]
5. Nausea and Vomiting: a Palliative Care Imperative.
Wickham RJ
Curr Oncol Rep; 2020 Jan; 22(1):1. PubMed ID: 31960161
[TBL] [Abstract][Full Text] [Related]
6. Oncology Patient Evidence-Based Notes (OPEN): antiemetics for chemotherapy-induced nausea and vomiting.
Cope D
Clin J Oncol Nurs; 2003; 7(4):461-2. PubMed ID: 12929282
[No Abstract] [Full Text] [Related]
7. Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy.
Atkinson SR
J Palliat Med; 2014 May; 17(5):503-4. PubMed ID: 24708452
[No Abstract] [Full Text] [Related]
8. Management of nausea and vomiting in palliative care.
Neoh K; Adkinson L; Montgomery V; Hurlow A
Br J Hosp Med (Lond); 2014 Jul; 75(7):391-2, 394-6. PubMed ID: 25040518
[TBL] [Abstract][Full Text] [Related]
9. An assessment of thiethylperazine (Torecan) in the control of radiation-induced nausea and vomiting.
Sicher K; Backhouse TW
Clin Radiol; 1968 Apr; 19(2):238-40. PubMed ID: 5652468
[No Abstract] [Full Text] [Related]
10. Chemotherapy-induced nausea and vomiting #285.
Tageja N; Groninger H
J Palliat Med; 2014 Dec; 17(12):1400-2. PubMed ID: 25401213
[No Abstract] [Full Text] [Related]
11. [The magic plant as an antiemetic. Cannabinoids for treatment of nausea and vomiting].
Kreutz S
Pharm Unserer Zeit; 2007; 36(5):389-92. PubMed ID: 17722146
[No Abstract] [Full Text] [Related]
12. Latest advances in the management of radiation-induced pain flare, nausea and vomiting.
Chiu N; Chiu L; Popovic M; DeAngelis C; Pasetka M; Lutz S; Zhang N; Marta GN; Mendez LC; Lechner B; Pulenzas N; Milakovic M; Chow R; Chow E
Ann Palliat Med; 2016 Jan; 5(1):50-7. PubMed ID: 26841815
[TBL] [Abstract][Full Text] [Related]
13. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
14. Mechanism and treatment of nausea and vomiting.
Nagendran T; Nagendran S
Ala Med; 1990 Nov; 60(5):12-6. PubMed ID: 2291448
[No Abstract] [Full Text] [Related]
15. Olanzapine in the Management of Difficult to Control Nausea and Vomiting in a Palliative Care Population: A Case Series.
MacKintosh D
J Palliat Med; 2016 Jan; 19(1):87-90. PubMed ID: 26398872
[TBL] [Abstract][Full Text] [Related]
16. [New aspects in the prevention and therapy of cytostatic drug-induced nausea and vomiting].
Evers C; Riess H
Z Arztl Fortbild (Jena); 1992 Sep; 86(17):847-53. PubMed ID: 1413901
[No Abstract] [Full Text] [Related]
17. Nausea and vomiting.
Supportive Oncology Services Inc
Oncology (Williston Park); 2007 Jul; 21(8 Suppl):2 p following 39. PubMed ID: 17844894
[No Abstract] [Full Text] [Related]
18. Management of nausea and vomiting caused by anticancer drugs: state of the art.
Pisters KM; Kris MG
Oncology (Williston Park); 1992 Feb; 6(2 Suppl):99-104. PubMed ID: 1532744
[TBL] [Abstract][Full Text] [Related]
19. Evolving treatment paradigms for chemotherapy-induced nausea and vomiting.
Wickham R
Cancer Control; 2012 Apr; 19(2 Suppl):3-9. PubMed ID: 22488022
[TBL] [Abstract][Full Text] [Related]
20. Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.
Priestman TJ
Can J Oncol; 1996 Feb; 6 Suppl 1():17-22. PubMed ID: 8853534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
